Loading clinical trials...
Loading clinical trials...
Adult IBS patients with symptoms refractory to standard medical treatment will receive online nurse-administered, gut-directed hypnotherapy in groups. The primary outcome measure was change in gastro-intestinal symptom severity. Secondary outcomes are GI-specific anxiety, general anxiety and depression, quality of life, and extracolonic symptom severity. Usability of the digital platform as well as patient treatment satisfaction will also be assessed.
IBS patients with symptoms refractory to standard treatment and who were referred to a specialist unit for hypnotherapy, will be included in the study consecutively. The patients will receive gut-directed hypnotherapy given by a nurse trained in Cognitive Behavioral Therapy (CBT) and hypnotherapy. Effects of treatment will be measured by validated questionnaires at baseline and at various time points during the treatment period, as well as after the completion of the treatment at follow-up 6 months, 1 and 2 years after treatment.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Mag-Tarmlab, Sahlgrenska University Hospital
Gothenburg, Sweden
Sahlgrenska University Hospital
Gothenburg, Sweden
Start Date
October 17, 2022
Primary Completion Date
May 30, 2025
Completion Date
May 30, 2025
Last Updated
January 12, 2026
50
ACTUAL participants
Gut-directed hypnotherapy
BEHAVIORAL
Lead Sponsor
Sahlgrenska University Hospital
NCT07089420
NCT06211062
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions